Fight Heart Disease with Exercise-Driven ApoA1 and HDL

🎧 ▶️ Press play below to listen.

Introduction: The HDL Paradox

For decades, the message has been simple: high-density lipoprotein (HDL) is the “good cholesterol.” Imagine a patient, reassured after a doctor’s visit, diligently taking a medication specifically prescribed to boost their HDL levels. The number on their latest blood test is higher than ever—a clear sign, they believe, of success in the fight against heart disease.

But what if that hard-won number was telling only half the story? What if the medication was elevating a metric that, while easy to measure, was missing the most critical part of the picture?

This is the HDL paradox. Groundbreaking research has revealed that the quantity of HDL cholesterol (HDL-C) in your blood is far less important than its quality and function. A medication can fill your bloodstream with HDL particles, but if they are dysfunctional—lazy, inefficient, or even harmful—that impressive number offers little real protection. This discovery explains the puzzling failure of some HDL-boosting drugs, which succeeded in raising the number but consistently failed to reduce heart attacks and strokes in large clinical trials.

So, if a pill that increases the number isn’t the silver bullet, what truly creates functional, heart-protective HDL? The answer lies not in a prescription bottle, but in a powerful, fundamental human activity: exercise.

This article will explore how exercise uniquely and masterfully optimizes your cardiovascular health by targeting the true engine of the HDL system—a protein called Apolipoprotein A1 (ApoA1). We will demystify how physical activity doesn’t just raise a passive number; it forges a superior, active defense system, simultaneously neutralizing your heart’s greatest threats and offering a level of protection that medications alone cannot replicate.

I. Demystifying the Players: ApoA1, HDL, and the Lipid Landscape

To understand why exercise is so transformative, we first need to move beyond the simplistic “good cholesterol” label and meet the key players in our story. The world of blood lipids is a complex transportation system, and knowing who does what is essential.

What is Apolipoprotein A1 (ApoA1)? The Master Conductor

If you think of cholesterol transport as a vital public transit network, then Apolipoprotein A1 (ApoA1) is the driver, engineer, and mission control for the “good” fleet.

Technically, ApoA1 is a protein. But it’s far from inert. It is the primary structural and functional component of High-Density Lipoprotein (HDL) particles. Without ApoA1, there is no HDL. Its roles are critical:

• Structural Scaffold: It forms a backbone that gives the HDL particle its shape.
• Cellular Key: It activates a process called reverse cholesterol transport—the crucial mechanism where excess cholesterol is picked up from artery walls and other tissues.
• System Director: It guides the HDL particle through the bloodstream, interacting with enzymes and receptors to determine its function and fate.

In short, while we measure the cholesterol inside the particle (HDL-C), it is the ApoA1 protein that does all the work. Measuring ApoA1 levels gives us a much better clue about how many of these functional “shuttles” are actually in circulation.

HDL Cholesterol (HDL-C): The Traditional, Incomplete Measure

This is the number most people are familiar with from their standard blood test. HDL-C measures the amount of cholesterol cargo being carried inside all your HDL particles. For a long time, it was assumed that more cargo meant more shuttles and better service.

However, we now know this is a flawed assumption. You could have a situation with very few, large, cholesterol-packed shuttles (giving a high HDL-C number) or a situation with many, small, empty shuttles (giving a low HDL-C number).

The total cargo count (HDL-C) doesn’t tell you about the number, size, or efficiency of the shuttles themselves. This is the fundamental limitation of relying solely on HDL-C.

The Nuance: HDL is Not a Single Entity—It’s a Diverse Fleet

This is perhaps the most critical concept to grasp. “HDL” is not one uniform thing. It’s a family of particles of different sizes and functions, broadly categorized into two main classes:

HDL2: The Large, Buoyant, “Mature” Particles

• Think of these as the high-capacity, long-haul trucks of the system.
• They are large, lipid-rich particles that are exceptionally efficient at the process of reverse cholesterol transport.
• They are considered the most directly cardioprotective members of the HDL family. A healthy system is rich in these mature particles.

HDL3: The Small, Dense, “Nascent” Particles

• These are the smaller, denser vans. They are newly assembled and are the initial acceptors of cellular cholesterol.
• While essential, a profile dominated by small, dense HDL3 particles is considered less protective.

Why does this matter? The function of your HDL system depends heavily on this mix. The goal isn’t just to have “more HDL”; it’s to have more of the right kind.

A successful system is one that efficiently takes the small HDL3 vans and matures them into the large, functional HDL2 trucks. This process of maturation is where lifestyle factors, especially exercise, play a decisive role, while some medications fall short.

In our next section, we’ll explore what happens when this system breaks down, and why a high HDL-C number can sometimes be a sign of a traffic jam rather than a smooth-flowing highway.

II. The Functionality Gap: Why a High HDL-C Number Can Be Deceiving

The previous chapter established a crucial distinction: HDL is not a single thing, and the standard cholesterol test gives an incomplete picture. Now, we confront the most counterintuitive concept in modern lipidology: a high HDL-C level does not automatically mean you are protected from heart disease. To understand why, we need to look at what your HDL particles are actually doing.

The “Useless Shuttle” Analogy

Imagine your bloodstream is a city, and your HDL particles are a fleet of garbage trucks (shuttles). Their vital job is to pick up toxic waste—excess cholesterol—from your artery walls and transport it to the liver for disposal. This process is known as Reverse Cholesterol Transport (RCT), and it is HDL’s primary cardioprotective function.

Now, consider two scenarios:

1. The Efficient Fleet: You have a large number of well-maintained, active trucks (functional HDL particles). They are constantly making pickups, efficiently moving through traffic, and successfully dumping their loads at the recycling plant (your liver). This system is highly protective.
2. The Inefficient Fleet (The “Useless Shuttle”): You have a fleet of trucks that are full of garbage (giving you a high HDL-C number), but they are broken down, have faulty GPS, or are stuck in a traffic jam. They are not making pickups, and they can’t unload their cargo. A measurement of the total garbage being carried (HDL-C) would look impressive, but the system is failing at its job. The waste is accumulating in the streets (your arteries).

This second scenario is the “Functionality Gap.” The quantity of cholesterol cargo is high, but the system’s function is broken. What broke the system? Read on.

Inflammation: The Saboteur of HDL Function

What causes a functional HDL particle to turn into a “useless shuttle”? The primary culprit is chronic, systemic inflammation.

Conditions like metabolic syndrome, diabetes, obesity, and smoking create a pro-inflammatory environment in the body. In this environment, HDL particles undergo a negative transformation. They become loaded with enzymes like Myeloperoxidase (MPO), which oxidizes and damages the ApoA1 protein.

• Damaged ApoA1 loses its ability to initiate reverse cholesterol transport.
• The HDL particle can become dysfunctional or even pro-inflammatory, meaning it starts to contribute to the problem in the artery walls instead of solving it.

This is why a person with chronic inflammation can have a high HDL-C level but still be at significant risk for heart disease. Their “good cholesterol” has been rendered useless, or even harmful, by their inflammatory state.

The Drug Trial Evidence: Proof That Quantity ≠ Benefits

The most powerful evidence for the functionality gap comes from pharmaceutical trials. For years, drug companies pursued medications designed to dramatically raise HDL-C levels, assuming this would inevitably prevent heart attacks.

The most telling examples are Niacin and a class of drugs called CETP Inhibitors. These drugs were spectacularly successful at their primary goal:

• Niacin can boost HDL-C levels by 20-30%.
• CETP Inhibitors could increase HDL-C by a staggering 50-100%.

Yet, when these drugs were put to the test in massive, long-term clinical trials involving tens of thousands of patients (such as the AIM-HIGH, HPS2-THRIVE, and ACCELERATE trials), the results were clear: despite the massive surge in HDL-C, there was no significant reduction in heart attacks, strokes, or deaths compared to standard care.

The conclusion was inescapable: Artificially inflating the number without improving the underlying function of the HDL particles is a futile exercise. The shuttles were full, but they were still broken.

In the next chapter, we will see how exercise succeeds where these drugs failed. It doesn’t just pack more cargo onto the shuttles; it builds a better, more resilient, and highly efficient fleet from the ground up.

III. Exercise as the Master Regulator: Forging Superior HDL

We have seen how a high HDL-C number can be an empty victory if the particles are dysfunctional. We’ve also witnessed the failure of drugs that tried to win the battle by numbers alone. So, what is the solution?

The answer lies in a powerful, natural process that doesn’t just add more shuttles to the road—it engineers a superior, more efficient fleet from the ground up. That process is exercise.

Exercise is the master regulator of the HDL system, working through multiple, synergistic pathways to enhance both the quantity and, most importantly, the quality of your ApoA1 and HDL particles.

1. Boosting the Production of ApoA1

The first and most direct effect is on the source. Regular physical activity, particularly sustained aerobic exercise like running, cycling, and swimming, acts as a signal to your body. This signal stimulates your liver and intestines—the primary production sites for ApoA1—to synthesize more of this crucial protein.

With more ApoA1 available, your body has the raw materials to construct new, functional HDL particles. This is a foundational step that medications like statins, which have a minimal impact on ApoA1, simply do not replicate.

2. Reshaping the Particle Profile: From Small Vans to Large Trucks

This is where exercise demonstrates its true sophistication. It doesn’t just create more particles; it actively reshapes the composition of your HDL fleet, favoring the most protective types.

• Promoting HDL2: Exercise consistently shifts the balance away from the small, dense HDL3 particles and toward the large, buoyant, and cardioprotective HDL2 particles. These are the “heavy-lifters” of reverse cholesterol transport, capable of carrying more cholesterol and interacting more effectively with the liver.
• The Triglyceride Connection: A key mechanism here is exercise’s potent effect on lowering blood triglycerides. High triglyceride levels fuel an unhealthy exchange where HDL particles lose their cholesterol core, becoming smaller and denser. By dramatically lowering triglycerides, exercise halts this process, allowing HDL particles to mature properly into the large, functional HDL2 subtype.

3. Enhancing Functional Quality: Building Smarter Shuttles

Beyond changing the shape, exercise fundamentally improves the operational capacity of each particle.

Supercharging Cholesterol Efflux: 

Studies show that exercise enhances the ability of HDL to perform its most critical job: cholesterol efflux. This is the process where HDL particles pull accumulated cholesterol out of immune cells (macrophages) in the artery wall, the foundational step in preventing plaque formation. Exercise makes your HDL better at this “garbage pickup” service.

Boosting Antioxidant and Anti-Inflammatory Capacity:

Recall that inflammation is the saboteur that renders HDL dysfunctional. Exercise is a powerful anti-inflammatory intervention. It helps create an environment where HDL particles are less likely to be damaged and are better equipped to perform their anti-inflammatory and antioxidant roles within the arterial wall.

In essence, exercise addresses the “Functionality Gap” at every level. It increases the production of the master conductor (ApoA1), assembles a fleet of the most effective vehicles (HDL2), and ensures they are operating in a clean, efficient environment free from inflammatory sabotage. It is a holistic, system-wide upgrade that no single pharmaceutical can match.

IV. The Medication Comparison: A Question of Quality vs. Quantity

When faced with the challenge of improving cholesterol numbers, the pharmaceutical approach has traditionally focused on a straightforward goal: move the needle on the lab report. However, as we’ve seen with the HDL functionality gap, this strategy has proven to be fundamentally limited.

Let’s compare how common lipid medications stack up against exercise in their effects on ApoA1 and the HDL system.

Statins: The Mainstream Choice with Modest HDL Impact

For the millions of people taking statins to lower their LDL cholesterol, it’s essential to understand what these medications do—and do not—do for their HDL system.

• Effect on ApoA1/HDL: Statins have a consistently modest and unreliable effect on raising ApoA1 and HDL-C. Most meta-analyses show they increase ApoA1 by only 3-5% and HDL-C by 5-10% at most. This is considered a minor, secondary effect of their primary LDL-lowering mechanism.
• The Context: While statins are foundational for reducing cardiovascular risk by aggressively lowering LDL-C and ApoB, they are not a solution for optimizing the protective, functional side of your lipid profile represented by ApoA1 and HDL.

Niacin: The Quantity King with Empty Promises

Niacin (vitamin B3) stands as the most potent pharmaceutical agent for increasing HDL-C and ApoA1 levels. In clinical settings, it can produce dramatic results:

• Magnitude of Increase: Niacin can boost ApoA1 levels by an impressive 15-25% and HDL-C by 20-35%—numbers that can dwarf the effects of exercise alone.
• Mechanism: It works primarily by slowing the liver’s breakdown of ApoA1, allowing HDL particles to circulate in the blood for longer and accumulate more cholesterol.
• The Critical Caveat: Despite these spectacular numerical improvements, niacin’s clinical legacy is one of disappointment.
  • Major outcomes trials—AIM-HIGH and HPS2-THRIVE—conclusively showed that adding niacin to statin therapy did not reduce heart attacks or strokes more than statins alone.
  • Furthermore, it came with significant side effects, including uncomfortable flushing, potential liver damage, and increased blood sugar.

The takeaway is stark: Niacin successfully fills the shuttles with cargo (raising HDL-C), but it does not fix a broken engine or a faulty GPS. It increases quantity without reliably improving functionality, proving that a higher number is not a meaningful victory if it doesn’t translate to better health.

Fibrates: A Modest, Indirect Boost

Fibrates (like fenofibrate and gemfibrozil) are another class of lipid drugs, primarily used to lower high triglycerides.

• Effect on ApoA1: They provide a more modest increase in ApoA1, typically in the range of 5-10%—a result that is highly comparable to what a consistent exercise program can achieve.
• Primary Benefit: Their main value lies in their potent triglyceride-lowering effect, which indirectly helps improve the HDL landscape by reducing the formation of the most dangerous, small-dense LDL particles.
• The Comparison: While fibrates can be a useful tool, their benefit for ApoA1 is similar to exercise, but without the broad, functional enhancements to the HDL particles themselves. They help clear the traffic jam (high TGs) but don’t necessarily build better shuttles.

Head-to-Head Comparison: Exercise vs. Drugs

When we place exercise alongside these medications, a clear distinction emerges:

Metric	Statins	Niacin	Fibrates	Exercise
ApoA1 Increase	Low (3-5%)	High (15-25%)	Moderate (5-10%)	Good (5-10%+)
HDL Function	Minimal / Uncertain Improvement	Not Improved / Uncertain	Modest Indirect Benefit	Dramatically Improved
Particle Quality	Minor change	No consistent positive change	Some improvement via lower triglycerides	Yes – promotes large, functional HDL2
Side Effects	Known profile (muscle, liver)	Significant (flushing, liver)	Some (GI, muscle)	Minimal. Mostly positive side effects

The Conclusion: The pursuit of health cannot be reduced to a single number on a lab report. Medications like niacin win the battle for quantity but lose the war for meaningful health outcomes because they ignore the critical dimension of functionality.

Exercise, while producing a more modest numerical increase, is unmatched in its ability to create a high-functioning, resilient HDL system. It enhances the very quality that makes HDL “good” in the first place, offering a safe, holistic, and effective path to genuine cardioprotection.

V. The Full Picture: Exercise, ApoB, and the Ultimate Heart Health Ratio

While the story of ApoA1 and functional HDL is crucial, it only tells half the tale of cardiovascular risk. To truly understand why exercise is such a powerful intervention, we must also meet its counterpart: Apolipoprotein B (ApoB). The interaction between these two systems, and how exercise masterfully optimizes their balance, represents the pinnacle of heart health protection.

Introducing the Villain: Apolipoprotein B (ApoB)

If ApoA1 is the master conductor of the “good” cholesterol shuttle system, then ApoB is the essential structural protein of the “bad” cholesterol delivery trucks. Specifically:

• One Per Particle: There is one ApoB molecule on every potentially atherogenic particle: very-low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and most importantly, low-density lipoprotein (LDL). This makes a blood test for ApoB the most accurate measure of the total number of these dangerous particles in your bloodstream.
• The Mechanism of Harm: These ApoB-containing particles penetrate the artery wall and become trapped, where they can become oxidized and trigger the inflammation that leads to plaque formation. The more ApoB particles you have, the greater the traffic jam in your arteries and the higher your risk of a cardiovascular event.

Exercise’s Powerful Dual-Action Benefit on ApoB

This is where exercise demonstrates its comprehensive impact. While discussions of HDL often overshadow its effect on ApoB, it is equally vital.

• Lowering Triglycerides to Reduce ApoB: Exercise is one of the most effective lifestyle strategies for lowering blood triglycerides. This is critically important because high triglyceride levels lead to the production of a greater number of the small, dense LDL particles—the most harmful and atherogenic type. By dramatically reducing the triglyceride raw material, exercise directly reduces the liver’s production of these dangerous ApoB-carrying particles.
• Enhancing Clearance: Regular physical activity has been shown to upregulate LDL receptors in the liver, improving the clearance of ApoB-containing particles from the bloodstream.

The result is a significant and consistent reduction in ApoB levels, complementing the functional improvements exercise makes to the ApoA1/HDL system.

The Gold Standard Ratio: ApoB/ApoA1

With a clear understanding of both players, we can now appreciate the ultimate biomarker for lipid-related heart disease risk: the ApoB/ApoA1 Ratio.

• What It Represents: This ratio is the balance between the total number of “bad” particles threatening your arteries (ApoB) and the total number of functional “good” particles protecting them (ApoA1). It is a direct measure of the traffic flow in your cardiovascular system.
• Predictive Power: Large-scale epidemiological studies, such as the INTERHEART study, have consistently found that the ApoB/ApoA1 ratio is one of the strongest predictors of global cardiovascular risk, outperforming traditional ratios like Total Cholesterol/HDL-C.

Exercise’s Masterstroke: Optimizing the Critical Balance

Exercise does not work on just one side of this equation. It performs a masterful balancing act:

1. It lowers the numerator (ApoB) by reducing the number of dangerous, atherogenic particles.
2. It improves the quality and function of the denominator (ApoA1), creating a more efficient and protective HDL fleet.

This dual-action effect creates a powerfully beneficial shift in the ApoB/ApoA1 ratio. While a drug might only move one number (like a statin powerfully lowering ApoB, or niacin weakly raising ApoA1), exercise simultaneously and harmoniously improves both sides of the equation. It doesn’t just tilt the scales; it creates a new, healthier equilibrium.

This holistic impact—reducing the threat while simultaneously enhancing the defense—is what sets exercise apart as a foundational, non-negotiable component of lifelong cardiovascular health.

VI. Your Action Plan: Practical Exercises to Boost ApoA1

Understanding the science is the first step; putting it into practice is what transforms your health. The evidence is clear: consistent, well-rounded physical activity is the most effective way to enhance your functional HDL system.

Here is your practical guide to designing an exercise regimen that will optimize your ApoA1, lower your ApoB, and forge a truly cardioprotective lipid profile.

1. The Foundation: Aerobic Exercise

Aerobic, or endurance, exercise is the cornerstone for stimulating the production of ApoA1 and promoting the formation of large, functional HDL2 particles.

• The Goal: Aim for at least 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity aerobic activity per week, as recommended by global health authorities.
• What is Moderate-Intensity? This is exertion where you can talk but not sing. Your breathing deepens, but you are not out of breath.
  • Examples: Brisk walking, leisurely cycling, water aerobics, or doubles tennis.
• What is Vigorous-Intensity? This is exertion where you cannot say more than a few words without pausing for breath.
  • Examples: Running, fast cycling, swimming laps, or high-impact aerobics.
• Practical Tip: Break this down into manageable sessions, such as 30 minutes of brisk walking, five days a week.
• Unlock Your Target Heart Rate Without A Monitor
• The Karvonen Target Heart Rate Calculator: A Smarter Way to Train Your Heart

2. The Metabolic Enhancer: High-Intensity Interval Training (HIIT)

For those looking to maximize efficiency and potentially enhance the functional benefits of their HDL, HIIT is an exceptionally powerful tool.

• The Goal: Incorporate a HIIT session 1-2 times per week, ensuring you have at least one day of rest or light activity between sessions to allow for recovery.
• What Does a HIIT Session Look Like? It involves short bursts of all-out effort followed by periods of active recovery.
  • A Simple Example: On a stationary bike, pedal as hard as you can for 30 seconds, then cycle slowly for 90 seconds. Repeat this cycle 6-8 times.
  • Another Example (Running): Sprint for 1 minute, then walk for 2 minutes. Repeat 5-7 times.
• Practical Tip: HIIT is demanding. If you are new to exercise, build a base of aerobic fitness for a few weeks before incorporating HIIT.
• How to Perform High-Intensity Interval Training

3. The Essential Support: Resistance Training

While aerobic exercise is the primary driver for ApoA1, resistance training plays a crucial supporting role by improving overall metabolic health and insulin sensitivity, which creates a better environment for functional HDL.

• The goal is to include strength training exercises that target all major muscle groups (legs, hips, back, chest, abdomen, shoulders, and arms) at least twice a week.
• What Does an Effective Session Include?
  • Examples: Exercises like squats, push-ups, rows, lunges, and shoulder presses.
  • Format: Aim for 2-3 sets of 8-12 repetitions for each exercise, using a weight or resistance that makes the last few repetitions challenging.
• Practical Tip: You don’t need a gym. Bodyweight exercises, resistance bands, or even heavy household items can provide an effective workout.
• Resistance Training

The Non-Negotiable Principle: Consistency is Key

The benefits to your ApoA1 and HDL system are not permanent. They are a direct result of your recent activity. The improvements you gain are maintained only as long as your exercise routine is sustained.

• Find Activities You Enjoy: You are far more likely to stick with a routine if you like it. Whether it’s dancing, hiking, a team sport, or weightlifting, the best exercise is the one you will do consistently.
• Think in Decades, Not Days: This is a lifelong investment in your cardiovascular machinery. View your exercise plan not as a short-term fix, but as a permanent part of your healthy lifestyle.

By combining these three pillars of fitness, you are not just chasing a number on a lab report. You are actively engaging in a daily practice that builds, repairs, and optimizes the very systems that protect your heart for a lifetime.

Conclusion: The Unbeatable Prescription for a Resilient Heart

The journey through the science of cholesterol reveals a profound shift in our understanding. The simplistic quest for a high “good cholesterol” number has been replaced by a more sophisticated goal: building a high-functioning, resilient HDL system.

We have seen that medications, while powerful for lowering the dangerous LDL and ApoB particles, largely fail to achieve this qualitative goal. They can fill the shuttles, but they cannot fix the engine.

Exercise stands apart as the ultimate prescription. It succeeds where pharmaceuticals fall short because it works in harmony with your biology. It doesn’t just add more ApoA1 to your bloodstream; it forges superior, functional HDL particles and shifts your profile towards the protective, large HDL2 subtype.

Simultaneously, it performs a masterful balancing act by reducing the number of atherogenic ApoB particles, thereby optimizing the crucial ApoB/ApoA1 ratio—a key marker of cardiovascular destiny.

This is not a passive treatment with a list of potential side effects. This is an active, empowering process. The side effects of this regimen are not muscle pains or cognitive fog, but increased energy, improved mood, and a stronger body.

The conclusion is inescapable: while medications have their vital place in managing high-risk conditions, consistent, well-rounded physical activity remains the most effective, safest, and most holistic strategy to build a truly resilient cardiovascular system from the inside out.

The power to forge a truly healthy heart doesn’t come from a pharmacy; it is built with every step, every pedal, and every lift.

Don’t Get Sick!

This information is for educational purposes. If you have concerns about your cholesterol levels or are new to exercise, please consult with your doctor or a qualified healthcare professional.

💡 Support This Work

Creating well-researched articles, maintaining this website, and keeping the information free takes time and resources.
If you found this article helpful, please consider donating to support the mission of empowering people to live healthier, longer lives, without relying on medications.

🙏 Every contribution, big or small, truly makes a difference. Thank you for your support!

Follow me on Facebook, Gab, Twitter (formerly known as X), and Telegram.

Related:

1. Saturated Fat and Heart Disease: Understanding the Latest Science
2. Machine Learning Finds Your Hidden Heart Disease Risks
3. ApoB Reveals Hidden Heart Disease And Diabetes Risk Early
4. How to Interpret ApoB and ApoA1 Results
5. ApoB vs LDL Cholesterol: Which Predicts Heart Attacks Better
6. CAC And CTA Scans Help Detect Heart Disease Early
7. ApoB and ApoA1 Best Predict Heart Attack: How To Get Tested
8. ApoB vs LDL Cholesterol: Which Predicts Heart Attacks Better
9. Heart Attack Risk? Use The Framingham Risk Calculator And Lower It Now!
10. Discover Your Cardiac Age with This Free Calculator
11. Heart Rate Recovery Reveals Hidden Secrets About Your Heart
12. Drink Coffee At This Time To Slash Heart Attack Risk
13. The FODMAP Trap That Mimics Heart Attacks During Exercise
14. The Hidden Link Between High Blood Sugar and Heart Attacks
15. Strep From the Mouth and Blood and Sudden Cardiac Death — What You Need to Know

References:

1. General Effect of Exercise on Lipids:
   • Wang Y, Xu D. Effects of aerobic exercise on lipids and lipoproteins. Lipids Health Dis. 2017 Jul 5;16(1):132. doi: 10.1186/s12944-017-0515-5. PMID: 28679436; PMCID: PMC5498979. https://pubmed.ncbi.nlm.nih.gov/28679436/
2. Meta-Analysis on Aerobic Exercise and Lipids:
   • HIIT and Cardiometabolic Health / HDL Functionality:
     • Ramos, J. S., Dalleck, L. C., Tjonna, A. E., Beetham, K. S., & Coombes, J. S. (2015). The impact of high-intensity interval training versus moderate-intensity continuous training on vascular function: a systematic review and meta-analysis. Sports Medicine, 45(5), 679-692. https://pubmed.ncbi.nlm.nih.gov/25771785/
     • Tjønna, A. E., Lee, S. J., Rognmo, Ø., et al. (2008). Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation, 118(4), 346-354. https://pubmed.ncbi.nlm.nih.gov/18606913/
3. Exercise and HDL Functionality (Cholesterol Efflux):
   • Ruiz-Ramie JJ, Barber JL, Sarzynski MA. Effects of exercise on HDL functionality. Curr Opin Lipidol. 2019 Feb;30(1):16-23. doi: 10.1097/MOL.0000000000000568. PMID: 30480581; PMCID: PMC6492243. https://pmc.ncbi.nlm.nih.gov/articles/PMC6492243/
4. Niacin Trial Failures (AIM-HIGH & HPS2-THRIVE):
   • The AIM-HIGH Investigators. (2011). Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. New England Journal of Medicine, 365(24), 2255-2267. https://www.nejm.org/doi/full/10.1056/NEJMoa1107579
   • HPS2-THRIVE Collaborative Group. (2014). Effects of extended-release niacin with laropiprant in high-risk patients. New England Journal of Medicine, 371(3), 203-212. https://www.nejm.org/doi/full/10.1056/NEJMoa1300955
5. CETP Inhibitor Trial Failure (ACCELERATE):
   • Lincoff, A. M., Nicholls, S. J., Riesmeyer, J. S., et al. (2017). Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease. New England Journal of Medicine, 376(20), 1933-1942. https://www.nejm.org/doi/full/10.1056/NEJMoa1609581
6. ApoB/ApoA1 Ratio as a Powerful Predictor (INTERHEART Study):
   • Yusuf, S., Hawken, S., Ôunpuu, S., et al. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet, 364(9438), 937-952. https://pubmed.ncbi.nlm.nih.gov/15364185/
7. Statins’ Effect on ApoA1/HDL (Meta-Analysis):
   • Barter, P., Gotto, A. M., LaRosa, J. C., et al. (2007). HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. New England Journal of Medicine, 357(13), 1301-1310. https://www.nejm.org/doi/full/10.1056/NEJMoa064278
   • Robinson, J. G., Wang, S., & Smith, B. J. (2009). Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. Journal of the American College of Cardiology, 53(4), 316-322. https://pubmed.ncbi.nlm.nih.gov/19161879/

© 2018 – 2025 Asclepiades Medicine, LLC. All Rights Reserved
DrJesseSantiano.com does not provide medical advice, diagnosis, or treatment

As an Amazon Associate, I earn from qualifying purchases